ROC Analysis of Prediction for Gastric Cancer Development Using Serum Pepsinogen and Helicobacter Pylori Antibody Tests

Abstract

antibiotics was monitored. The cost effectiveness between the different phases were calculated. RESULTS: Of 106 patients, 53 were in each phase-case record analysis and observational phase. It was found that the length of stay was directly proportional to the duration of therapy which was more significant among converted. In the first phase, out of 68 parenteral antibiotic courses, 44 (64.7%) were converted and in the second phase, out of 60, 29 (48.3%) were converted. 64.7% patients were switched to oral antibiotics. Switch therapy was most frequent type of conversion with a mean time of 7.3±4.2 days in phase I and 5.5±2.7 days in phase II. The workload of nurses was reduced by 15 hours and the average cost from 4480.29 INR to 4171.5 INR. CONCLUSIONS: Guidelines may facilitate appropriate use of parenteral antibiotics with earlier switching to oral therapy. The clinical pharmacist has an important role in promoting and maintaining appropriate prescribing of parenteral antibiotics.